A new study suggests that semaglutide, the drug behind Ozempic and Wegovy, could offer unexpected benefits for mental health. It may reduce the risk of psychiatric hospitalizations by 21% in people with bipolar disorder.
מקור: Latest Science News — ScienceDaily — לכתבה המלאה
כתיבת תגובה